Healthpeak Properties, Inc. (DOC)

FairStock Score: 44/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I start with the asset and the filed record. Healthpeak owns healthcare discovery and delivery real estate, a business that can be durable if occupancy and rents hold. But the numbers are uneven: FY2025 revenue was $604.0M versus $568.5M in FY2024, while net income fell to $71.3M from $243.1M and diluted EPS dropped to $0.10 from $0.36. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $216.5M and net income $52.8M, but one quarter does not offset the weak multi-year profit trend. FairStock labels this a slow grower that is shrinking, citing profit of -29.6% a year over five years and revenue growth of 6.7%. For a REIT, EPS and P/E are distorted by depreciation; FFO/AFFO are the right measures, and they are not in the data. So I lean on dividend yield, leverage, revenue trend and price-to-book. At the 2026-10-26 close of $19.36, FairStock shows a 6.00% dividend yield, a 1.70 price-to-book and a 9.2% FCF yield. That looks fair to slightly cheap, and the 7/9 Piotroski score is a modest positive. But debt/equity of 1.09 and an Altman Z-score of 0.70 mean the balance sheet deserves close attention. I see a mixed REIT, not a clear bargain.

In plain English: Healthpeak owns and operates healthcare real estate, including properties for medical discovery and delivery. Revenue has been rising, but profits have been uneven and fell sharply in fiscal 2025, so the business looks mixed rather than clearly strong. At $19.36, the shares look roughly fair to slightly cheap versus their accounting value, with a high dividend yield but meaningful debt.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer